Top Banner
MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA
22

MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

Dec 31, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS

Stephen F. Daugherty, MD, FACSClarksville, Tennessee, USA

Page 2: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

NO RELEVANTCONFLICTS OF INTEREST

Page 3: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

ENDOVENOUS HEAT-INDUCED THROMBUS

DEEP VEIN THROMBOSIS

INCIDENCE IN LITERATURE SURVEY

RADIOFREQUENCY ABLATION (RFA) 0-16%

ENDOVENOUS LASER ABLATION (EVLA) 0-8%

Page 4: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

NATIONAL SURGICAL QUALITY IMPROVEMENT PROJECT

3874 PATIENTS, 2005-2009

EHIT/DVT PERFA 1.74% 0EVLA 1.52% 2 (0.05%)

Bennaroch-Gampel, et al. J Vasc Surg Venous 2013; 1: 26-32.

Page 5: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

COMPLICATIONS OF ENDOVENOUS ABLATION IN RANDOMIZED CONTROLLED TRIALS (17)

EHIT DVTSVT PE

RFA 0 0 18 (5.4%) 1330 LIMBS

EVLA 7 (0.7%) 2 (0.2%) 53/947 01009 LIMBS (5.6%)

Dermody, et al. J Vasc Surg:Venous pub online 08 July 2013

Page 6: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

RADIOFREQUENCY ABLATION6707 LIMBS TREATED

EHIT DVTPE

201 (3%) 9 2Sufian, et al. J Vasc SurgVenous 2013; 1:159-

164

Page 7: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

PuggianiMarshSadek/KabnikHaqqaniRavi

NUMBER130

28203083

733000

EHIT DVT3 (2.3%) 0

7(0.25% 14(0.5%)174(2.4%) 0 0

2(2.7%)0 0 1

Page 8: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 9: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 10: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 11: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

ENDOVENOUS HEAT-INDUCED THROMBUS

CLASS 1CLASS 2

CLASS 3

CLASS 4

- OBSERVATION OR ANTIPLATELET RX- LOW MOLECULAR WEIGHT HEPARIN OR ANTIPLATELET AGENTS WEEKLY ULTRASOUND FOLLOW-UP - LOW MOLECULAR WEIGHT HEPARIN +- ORAL ANTICOAGULATION- LOW MOLECULAR WEIGHT HEPARIN AND ORAL ANTICOAGULATION

Page 12: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 13: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

SECONDARY THROMBOSISSAPHENOUS TRIBUTARIES

NONSTEROIDAL ANTI-INFLAMMATORIESASPIRINELASTIC COMPRESSIONWARM COMPRESSES IF DESIREDLOW MOLECULAR WEIGHT HEPARIN?

- DEPENDING ON SEVERITY- ANTI-INFLAMMATORY EFFECT

Page 14: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

DEEP VEIN THROMBOSIS

EXTENSION OF SVT VIA PERFORATOR

AT A REMOTE SITEUSUALLY CALF VEINS

Page 15: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 16: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

TREATMENT OF DVT

FULL ANTICOAGULATION- LMWH AND WARFARIN, OR- NOVEL ANTICOAGULANT

COMPRESSIONAMBULATIONPERIODIC ELEVATIONTHROMBOPHILIA WORK-UP

Page 17: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

PULMONARY EMBOLUS

ANTICOAGULATIONIV HEPARIN INITIALLY; THEN

LMWH AND WARFARIN ORNOVEL ANTICOAGULANT

BILATERAL LOWER EXTREMITY DUPLEX USABDOMINAL VENOUS DUPLEX USTHROMBOPHILIA WORK-UP

Page 18: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Page 19: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

ISCHEMIC NEUROLOGIC EVENTS

ONE PUBLISHED REPORT-Caggiali, Franceschini, J Vasc Surg 2010

TENNESSEE45 Y/O REGISTERED NURSETRANSIENT UPPER EXT WEAKNESS AND

LOSS OF CONSCIOUSNESS20 DAYS AFTER RFA BILATERAL

ANTERIOR ACCESSORY SAPHENOUS VEINS

Page 20: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

- LARGE PATENT FORAMEN OVALE

- 55 DAYS AFTER ABLATION AND 35 DAYS AFTER STROKE, LOWER EXTREMITY DUPLEX US SHOWS A VERY SMALL AMOUNT OF THROMBUS IN A FOCAL DILATATION (12 mm) OF A GSV

Page 21: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.

STROKE MANAGEMENT

MAGNETIC RESONANCE IMAGING OF BRAINNEUROLOGIC CONSULTATION

EVALUATE FOR ANTICOAGULATION ORTHROMBOLYSIS

BILATERAL LOWER EXTREMITY DUPLEX USCARDIAC ECHO WITH BUBBLE TEST FOR PFOCAROTID DUPLEX USABDOMINAL VENOUS DUPLEX US?

Page 22: MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.